Global and Region Blocker Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Blocker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Blockermarket, defines the market attractiveness level of Blocker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Blocker industry, describes the types of Blocker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blocker market and the development prospects and opportunities of Blocker industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blocker market in Chapter 13.

    By Player:

    • Astra Zeneca

    • Bayer

    • Merck

    • Novartis

    • GSK

    • Eli Lilly and Company

    • Jhonson and Johnson

    • Bristol-Myers Squibb

    • Teva Pharmaceutical

    • Sanofi SA

    • Pfizer

    By Type:

    • Non-selective Antagonists

    • Selective Antagonists

    By End-User:

    • Hypertension

    • Raynaud's Disease

    • Erectile Dysfunction

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Blocker Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Blocker Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Blocker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Blocker Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Blocker Market Analysis and Outlook to 2022

    • 7.1 Global Blocker Consumption (2017-2022)

    • 7.2 United States Blocker Consumption (2017-2022)

    • 7.3 Europe Blocker Consumption (2017-2022)

    • 7.4 China Blocker Consumption (2017-2022)

    • 7.5 Japan Blocker Consumption (2017-2022)

    • 7.6 India Blocker Consumption (2017-2022)

    • 7.7 South Korea Blocker Consumption (2017-2022)

    8 Region and Country-wise Blocker Market Analysis and Outlook to 2028

    • 8.1 Global Blocker Consumption Forecast (2022-2028)

    • 8.2 United States Blocker Consumption Forecast (2022-2028)

    • 8.3 Europe Blocker Consumption Forecast (2022-2028)

    • 8.4 China Blocker Consumption Forecast (2022-2028)

    • 8.5 Japan Blocker Consumption Forecast (2022-2028)

    • 8.6 India Blocker Consumption Forecast (2022-2028)

    • 8.7 South Korea Blocker Consumption Forecast (2022-2028)

    9 Global Blocker Market Outlook by Types and Applications to 2022

    • 9.1 Global Blocker Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Selective Antagonists Consumption and Growth Rate (2017-2022)

    • 9.2 Global Blocker Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Raynaud's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)

    10 Global Blocker Market Outlook by Types and Applications to 2028

    • 10.1 Global Blocker Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Blocker Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)

    11 Global Blocker Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Blocker Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Blocker Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Blocker Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Blocker Market Competitive Analysis

    • 14.1 Astra Zeneca

      • 14.1.1 Astra Zeneca Company Details

      • 14.1.2 Astra Zeneca Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astra Zeneca Blocker Product and Service

    • 14.2 Bayer

      • 14.2.1 Bayer Company Details

      • 14.2.2 Bayer Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer Blocker Product and Service

    • 14.3 Merck

      • 14.3.1 Merck Company Details

      • 14.3.2 Merck Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck Blocker Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Blocker Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Blocker Product and Service

    • 14.6 Eli Lilly and Company

      • 14.6.1 Eli Lilly and Company Company Details

      • 14.6.2 Eli Lilly and Company Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly and Company Blocker Product and Service

    • 14.7 Jhonson and Johnson

      • 14.7.1 Jhonson and Johnson Company Details

      • 14.7.2 Jhonson and Johnson Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Jhonson and Johnson Blocker Product and Service

    • 14.8 Bristol-Myers Squibb

      • 14.8.1 Bristol-Myers Squibb Company Details

      • 14.8.2 Bristol-Myers Squibb Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bristol-Myers Squibb Blocker Product and Service

    • 14.9 Teva Pharmaceutical

      • 14.9.1 Teva Pharmaceutical Company Details

      • 14.9.2 Teva Pharmaceutical Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teva Pharmaceutical Blocker Product and Service

    • 14.10 Sanofi SA

      • 14.10.1 Sanofi SA Company Details

      • 14.10.2 Sanofi SA Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi SA Blocker Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Blocker Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Blocker

    • Figure Blocker Picture

    • Table Global Blocker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blocker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blocker Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Blocker Consumption by Country (2017-2022)

    • Figure United States Blocker Consumption and Growth Rate (2017-2022)

    • Table Europe Blocker Consumption and Growth Rate (2017-2022)

    • Figure China Blocker Consumption and Growth Rate (2017-2022)

    • Figure Japan Blocker Consumption and Growth Rate (2017-2022)

    • Figure India Blocker Consumption and Growth Rate (2017-2022)

    • Figure South Korea Blocker Consumption and Growth Rate (2017-2022)

    • Figure Global Blocker Consumption Forecast by Country (2022-2028)

    • Figure United States Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Selective Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Raynaud's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)

    • Figure Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Blocker Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Blocker Export by Region (Top 5 Countries) (2017-2028)

    • Table Astra Zeneca (Foundation Year, Company Profile and etc.)

    • Table Astra Zeneca Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astra Zeneca Blocker Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Blocker Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Blocker Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Blocker Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Blocker Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Blocker Product and Service

    • Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Jhonson and Johnson Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jhonson and Johnson Blocker Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Blocker Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Blocker Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Blocker Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Blocker Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.